Clinical Trial Update: Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing bortezomib and dexamethasone followed by autologous stem cell transplant versus autologous stem cell transplant alone has completed in A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Amyloidosis | Phase 3 | Status: COMPLETED